http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20090131726-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b1fd62f6c68492a0b2b26bc48747778 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-115 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2533-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2509-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0639 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0784 |
| filingDate | 2008-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf41e799799c1f0cab5fe90f63fefc9f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41f03ab90d419016b730a96bff613ec4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24075c86ab2692cae375c711c7d32ebe http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4f58f1407c08163ec58d480e73269aa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_552dfebcbf11b761c8d0ee1752b25cb0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75bbfbd57fb405fb13f16b588bd8425d |
| publicationDate | 2009-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20090131726-A |
| titleOfInvention | Method for producing dendritic cells from peripheral blood monocytes with high efficiency |
| abstract | According to the present invention, a single cell isolated from peripheral blood mononuclear cells is cultured in a flask coated with a hydrogel that does not adhere well to cells such as poly (2-hydroxyethyl metacrylate), polymethyl methacrylate, and the like to differentiate into dendritic cells. It relates to a method for producing dendritic cells to increase the function and yield (living cells).n n n According to the present invention, in order to overcome the limitations of the conventional dendritic cell culture, since a single cell is separated from peripheral blood mononuclear cells and differentiated into dendritic cells in a hydrogel-coated culture vessel, there is always enough cells of dendritic cells in each preparation. Since the number (capacity of recovery) and function can be secured, it is possible to provide cancer patients with cancer cancer cell therapy with high quality that can enhance antitumor effect. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101440102-B1 |
| priorityDate | 2008-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 83.